Clinical Trials

Clinical trials determine if a therapy is safe and effective for patients. We have initiated Phase 1 studies for our Treg therapy and completed the trial for our Teff biologic.

7101 Clinical Trial for Rheumatoid Arthritis

We have initiated a Phase 1 study to evaluate the safety and proof-of-mechanism of our lead Treg cell therapy candidate, SBT-77-7101, in patients with rheumatoid arthritis.

For more information, please visit our clinical trial website.

Learn More

7101 Clinical Trial for Hidradenitis Suppurativa

This study will test the safety and effects of SBT-77-7101 when given as a single dose to subjects with hidradenitis suppurativa. Increasing dose levels will be given after the safety at lower dose levels is shown.

For more information, please visit our clinical trial website.

Learn More

5301 Clinical Trial

We have completed a Phase 1 study of SBT-11-5301, our effector T cell-modulating biologic, in healthy participants.

For more information, please see the 5301 study on ClinicalTrials.gov.

Learn More